XML 77 R66.htm IDEA: XBRL DOCUMENT v3.4.0.3
Supplemental Guarantor Information - Unaudited Consolidating Statements of Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities $ (59,885) $ (202,916)
Cash flows from investing activities:    
Capital expenditures (6,017) (7,478)
Proceeds from sale of fixed assets 2,471 0
Investments in unconsolidated entities (2,787) (1,670)
Proceeds from sale of unconsolidated entities 1,141 24,211
Increases in restricted cash (1,770) (2,487)
Decreases in restricted cash 23,392 22,259
Advances to/from subsidiaries 0 0
Net cash provided by investing activities 16,430 34,835
Cash flows from financing activities:    
Repayment of debt (208,221) (9,514)
Proceeds from issuance of new debt 137,900 0
Borrowings from credit facility 25,000 0
Repayment of borrowings from credit facility (25,000) 0
Debt issuance costs (2,451) (126)
Dividends paid   0
Advances to/from subsidiaries 0 0
Other financing activities (423) (172)
Net cash used in financing activities (73,195) (9,812)
Decrease in cash and cash equivalents (116,650) (177,893)
Cash and cash equivalents at beginning of period 251,583 324,154
Cash and cash equivalents at end of period 134,933 146,261
Beazer Homes USA, Inc.    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities (32,839) (31,274)
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0  
Investments in unconsolidated entities 0 0
Proceeds from sale of unconsolidated entities 0 0
Increases in restricted cash (656) (1,319)
Decreases in restricted cash 22,368 21,601
Advances to/from subsidiaries (17,322) (145,846)
Net cash provided by investing activities 4,390 (125,564)
Cash flows from financing activities:    
Repayment of debt (203,679) (8,702)
Proceeds from issuance of new debt 137,900  
Borrowings from credit facility 25,000  
Repayment of borrowings from credit facility (25,000)  
Debt issuance costs (2,451) (126)
Dividends paid   500
Advances to/from subsidiaries 0 0
Other financing activities (423) (172)
Net cash used in financing activities (68,653) (8,500)
Decrease in cash and cash equivalents (97,102) (165,338)
Cash and cash equivalents at beginning of period 232,226  
Cash and cash equivalents at end of period 135,124 136,642
Guarantor Subsidiaries    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities (26,968) (171,497)
Cash flows from investing activities:    
Capital expenditures (6,017) (7,478)
Proceeds from sale of fixed assets 2,471  
Investments in unconsolidated entities (2,787) (1,670)
Proceeds from sale of unconsolidated entities 1,141 24,211
Increases in restricted cash (1,114) (1,168)
Decreases in restricted cash 1,024 658
Advances to/from subsidiaries 0 0
Net cash provided by investing activities (5,282) 14,553
Cash flows from financing activities:    
Repayment of debt (4,542) (812)
Proceeds from issuance of new debt 0  
Borrowings from credit facility 0  
Repayment of borrowings from credit facility 0  
Debt issuance costs 0 0
Dividends paid   0
Advances to/from subsidiaries 20,888 147,759
Other financing activities 0 0
Net cash used in financing activities 16,346 146,947
Decrease in cash and cash equivalents (15,904) (9,997)
Cash and cash equivalents at beginning of period 21,543  
Cash and cash equivalents at end of period 5,639 12,037
Non-Guarantor Subsidiaries    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities (78) (145)
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0  
Investments in unconsolidated entities 0 0
Proceeds from sale of unconsolidated entities 0 0
Increases in restricted cash 0 0
Decreases in restricted cash 0 0
Advances to/from subsidiaries 0 0
Net cash provided by investing activities 0 0
Cash flows from financing activities:    
Repayment of debt 0 0
Proceeds from issuance of new debt 0  
Borrowings from credit facility 0  
Repayment of borrowings from credit facility 0  
Debt issuance costs 0 0
Dividends paid   (500)
Advances to/from subsidiaries 12 12
Other financing activities 0 0
Net cash used in financing activities 12 (488)
Decrease in cash and cash equivalents (66) (633)
Cash and cash equivalents at beginning of period 1,006  
Cash and cash equivalents at end of period 940 981
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0  
Investments in unconsolidated entities 0 0
Proceeds from sale of unconsolidated entities 0 0
Increases in restricted cash 0 0
Decreases in restricted cash 0 0
Advances to/from subsidiaries 17,322 145,846
Net cash provided by investing activities 17,322 145,846
Cash flows from financing activities:    
Repayment of debt 0 0
Proceeds from issuance of new debt 0  
Borrowings from credit facility 0  
Repayment of borrowings from credit facility 0  
Debt issuance costs 0 0
Dividends paid   0
Advances to/from subsidiaries (20,900) (147,771)
Other financing activities 0 0
Net cash used in financing activities (20,900) (147,771)
Decrease in cash and cash equivalents (3,578) (1,925)
Cash and cash equivalents at beginning of period (3,192)  
Cash and cash equivalents at end of period $ (6,770) $ (3,399)